# FDA 483 - Maria Alora Palli, M.D. - April 29, 2019

Source: https://www.keypedia.com/records/483/maria-alora-palli-md/1f774ec4-87d5-4cf7-816e-118e6e284571

> FDA 483 for Maria Alora Palli, M.D. on April 29, 2019. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Maria Alora Palli, M.D.
- Inspection Date: 2019-04-29
- Product Type: other
- Office Name: Division of Northeast Imports 
- Summary: An FDA inspection of Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS) in Boston, MA, revealed a significant issue regarding adherence to investigational plans. The firm failed to conduct an investigation in accordance with its protocol, specifically concerning the administration of instructions to study subjects. This indicates a deviation from established clinical trial procedures.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)
- [Podcast Host](https://www.keypedia.com/people/john-l-zaccone/ed9f0de9-fda1-47d8-8aa7-79baa3b6c131)

Company: https://www.keypedia.com/companies/maria-alora-palli-md/b132c050-bd54-443d-bc3c-41947d3cf5e1

Office: https://www.keypedia.com/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94